Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $639.41 billion, total revenue of $165.59 billion and a weighted average PE ratio of 36.35.
Market Cap
639.41B
Revenue
165.59B
Profits
17.59B
PE Ratio
36.35
Profit Margin
10.62%
Dividend Yield
0.25%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 179.14B | 1.87% | 879,375 | 44.56B |
| 2 | DHR | Danaher Corporation | 129.89B | 1.11% | 2,415,621 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.56B | 0.23% | 193,145 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 31.69B | 1.72% | 771,467 | 7.07B |
| 5 | WAT | Waters Corporation | 28.84B | 1.67% | 358,156 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.04B | 1.94% | 695,438 | 16.31B |
| 7 | NTRA | Natera, Inc. | 26.36B | 1.83% | 619,766 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 25.31B | 1.45% | 58,644 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.83B | 0.28% | 323,868 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.66B | 0.82% | 312,433 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 18.49B | 2.74% | 766,349 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 13.11B | 2.42% | 100,599 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 11.21B | 0.99% | 1,250,384 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 9.45B | 0.75% | 511,968 | 2.86B |
| 15 | ICLR | ICON Public Limited Company | 8.09B | 3.77% | 647,758 | 8.10B |
| 16 | QGEN | Qiagen N.V. | 8.08B | 0.29% | 949,633 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.95B | 1.50% | 315,777 | 4.02B |
| 18 | RDNT | RadNet, Inc. | 4.35B | -0.11% | 333,080 | 2.04B |
| 19 | SHC | Sotera Health Company | 3.77B | 0.99% | 764,638 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.23B | 0.90% | 196,672 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 2.64B | -3.12% | 557,188 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.43B | 1.73% | 864,639 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 1.90B | -4.33% | 413,087 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.76B | 5.45% | 764,470 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 933.35M | - | 639,216 | 727.33M |
| 26 | CDNA | CareDx, Inc. | 843.53M | -1.85% | 341,898 | 379.81M |
| 27 | OPK | OPKO Health, Inc. | 834.97M | -1.79% | 1,993,075 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 706.71M | 1.02% | 128,180 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 644.01M | -2.92% | 919,679 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 490.63M | 0.77% | 190,697 | 322.67M |
| 31 | MYGN | Myriad Genetics, Inc. | 404.89M | 1.17% | 700,152 | 824.50M |
| 32 | PRE | Prenetics Global Limited | 331.52M | -3.90% | 124,775 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 175.50M | -0.37% | 36,909 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 134.96M | -3.66% | 47,297 | 88.50M |
| 35 | FONR | FONAR Corporation | 121.54M | -0.16% | 16,245 | 106.03M |
| 36 | MDXH | MDxHealth SA | 117.11M | -6.56% | 243,900 | 107.88M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 82.19M | -28.23% | 274,088 | 4.06M |
| 38 | XGN | Exagen Inc. | 63.50M | -1.49% | 82,893 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 43.10M | -5.28% | 9,334 | 22.80M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 16.45M | -8.50% | 1,096,232 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 11.01M | -7.93% | 50,776 | - |
| 42 | NOTV | Inotiv, Inc. | 8.60M | -7.44% | 485,197 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 6.40M | -7.49% | 257,390 | 29.52M |
| 44 | ADVB | Advanced Biomed Inc. | 5.89M | 3.28% | 12,285 | - |
| 45 | NDRA | ENDRA Life Sciences Inc. | 5.47M | 7.82% | 22,148 | - |
| 46 | QUCY | Mainz Biomed N.V. | 5.26M | -4.55% | 181,939 | 659.94K |
| 47 | ISPC | iSpecimen Inc. | 1.36M | -4.93% | 770,314 | 3.35M |